New Study Finds 'O Shot' May Help Women with Sexual Dysfunction
A groundbreaking new study has revealed that women struggling with sexual dysfunction could potentially benefit from a treatment commonly referred to as the 'O shot'. This innovative approach involves injecting platelet-rich plasma (PRP) into vaginal tissue, and experts believe it may offer relief for thousands of women experiencing debilitating symptoms often associated with menopause.
Study Details and Methodology
The research, published in the prestigious journal Obstetrics & Gynecology, followed 52 sexually active premenopausal women aged between 18 and 50 years old over a six-month period. Participants were recruited from a urology clinic and randomly assigned to receive either a single PRP injection or a saline placebo injection into the front wall of the vagina.
Injections were administered at three specific points near the vaginal opening and approximately 3cm from the urethra, which is the tube through which urine exits the body. Crucially, the study was conducted as a double-blind trial, meaning neither the women nor the researchers knew which participants received the active treatment versus the placebo.
Promising Results Despite Statistical Limitations
Women who received the PRP treatment demonstrated greater improvement in sexual function after both six weeks and six months compared to those who received the saline placebo. Specifically, those treated with PRP reported enhanced sexual desire, increased arousal, better lubrication, and more frequent orgasms than before the treatment began.
While the researchers noted that these changes were not statistically significantly different from the control group when measured objectively, the subjective experiences told a compelling story. Just six weeks after treatment, nearly 70% of women who received PRP injections reported improved sexual function based on their personal experience, compared to only 42% of those who received placebo shots.
Understanding the 'O Shot' Treatment
The treatment, popularly known as the 'O shot', involves injecting a patient's own platelet-rich plasma into vaginal tissue. To obtain PRP, medical professionals draw a syringe of blood from the patient's arm and spin it in a centrifuge until the plasma separates from the red blood cells. This plasma is packed with platelets and growth factors that can stimulate cell regeneration when reinjected into the body.
This mechanism explains why PRP has seen growing use in various beauty treatments and cosmetic procedures, though its application for sexual dysfunction represents a newer frontier in medical research.
Context of Menopause and Sexual Health
It is not uncommon for women to experience a decline in sexual desire during the five to ten years leading up to menopause, a transitional period known as perimenopause. During this time, sex hormones including oestrogen rapidly decline, affecting everything from mood to physical changes in the pelvic floor and vaginal area.
Reduced blood flow to the genital region causes tissue to thin, leading to vaginal atrophy, dryness, and tightness that can result in irritation, recurrent urinary tract infections, and pain during sexual intercourse. While many women report that PRP injections increase sensitivity and boost sex drive, the treatment remains experimental and is not currently available through the National Health Service.
Treatment Accessibility and Considerations
Sometimes referred to as the 'O shot', PRP injections can cost anywhere from £250 for a single injection to upwards of £1,500 at private clinics in the United Kingdom. While many proponents claim the treatment can improve sensitivity and make orgasms more likely, it does not always help alleviate pain during sex, where a lack of oestrogen is more likely to be the underlying problem.
The researchers from the University of Colorado Anschutz concluded that their randomized controlled trial provides compelling data demonstrating greater improvement in sexual function with PRP injections compared to control treatments in sexually active premenopausal women without severe sexual dysfunction.
The Growing Menopause Market
It is currently estimated that the menopause market will reach £20 billion by 2030, with many women now choosing alternatives to traditional hormone replacement therapy (HRT). This shift comes despite concerns about increased breast cancer risk associated with HRT that have since been largely disproven.
HRT works by artificially producing hormones that the body no longer produces naturally, helping to alleviate common menopause symptoms such as vaginal dryness and hot flushes. The emergence of treatments like the 'O shot' represents another option in an expanding landscape of menopause-related healthcare solutions.
